EPH19 Long Term Epidemiological Impact of Adjuvant Atezolizumab in Preventing the Recurrence of Early PDL1 High Non-Small Cell Lung Cancer in Europe
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.941
https://www.valueinhealthjournal.com/article/S1098-3015(22)03146-1/fulltext
Section Title :
Section Order :
10484
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03146-1&doi=10.1016/j.jval.2022.09.941